Keerti Mishra
CSIR-Central Drug Research Institute, Guru Ghasidas Vishwavidyalaya, Dr. A.P.J. Abdul Kalam Technical University
About
Keerti Mishra is a pharmaceutical researcher specializing in nanomedicine and advanced drug delivery systems. Her work focuses on the rational design, optimization and preclinical evaluation of multifunctional nanoparticle platforms to enhance therapeutic efficacy across diverse diseases. She has expertise in nanoformulation development, physicochemical characterization, pharmacokinetic evaluation and regulatory-compliant analytical method validation. Her research integrates material science with translational pharmacology to advance targeted and clinically relevant nanotherapeutics.
Employment
-
CSIR-Central Drug Research Institute Research Scholar2021 - Present
Education
-
Guru Ghasidas Vishwavidyalaya M. Pharm2018 - 2020
-
Dr. A.P.J. Abdul Kalam Technical University B. Pharm2014 - 2018
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- Targeting Alzheimer's pathophysiology with carbon dots: from mechanisms to therapy Save
- Receptor-ligand-based targeting approaches in breast cancer Save
- Simultaneous estimation of donepezil and quercetin using ultra high performance liquid chromatography: pharmaceutical and pharmacokinetic applications in Alzheimer’s disease Save
- Cerium-based nanoparticles for neurodegeneration: emerging redox therapeutics beyond pharmaceuticals Save
- Designing pegylated dextran sheathed doxorubicin loaded iron nanoparticles against premenopausal breast cancer Save
- Magnetically responsive and thermo-responsive vesicular carriers for improved drug delivery to tumors Save
- Metallic nanoparticles for photodynamic cancer therapy Save
- Nanotechnology Assisted Drug Delivery Strategies for Chemotherapy: Recent Advances and Future Prospects Save
- Network pharmacology and protective effect of HPLC-PDA validated flavonoid rich Carica papaya for the treatment of thrombocytopenia Save
- Neuronal Membrane-Coated Mesoporous Ceria Nanoparticles for Blood-Brain Barrier Crossing and Mitigation of Neurodegeneration Save